Academics
follow us
  • Linkedin
  • Twitter
  • Facebook
  • Youtube
  • Instagram
Feedback
Patent Number:- IN405368

Indolyl Oxoacetamide Analogues as Potent Pancreatic Lipase Inhibitors

  • Sector: Pharmaceutical Technology,
  • IPC: C07D, A23L,
 

Need

Current anti-obesity drugs lack safety and efficacy, necessitating the development of safer and more effective alternatives.

Solution

The invention provides a formulation comprising indolyl oxoacetamide compounds, presenting a potential solution for addressing obesity.

Innovation

The invention introduces novel indolyl oxoacetamide compounds with specific structural features and their pharmaceutical formulations as potent pancreatic lipase inhibitors, offering a new approach to combat obesity.

Market Analysis

Market: Obesity Management, Pharmaceutical Industry

CAGR: High, due to increasing global obesity rates

Potential Indian Clients: Pharmaceutical Companies, Research Institute

Why Invest?


Pharmaceutical formulations

Pancreatic Lipase inhibitors

Obesity

Cetilistat

At a Glance


Current TRL: NA

Funded by: NA

IPC: A23L, C07D

Domain: Pharmaceutical Development

For more information, reach out to Mr. Rajneesh Kumar, Head of the Technology Transfer Office, at tto@bits-pilani.ac.in and 01596-255515.